440例下肢淋巴水肿患者的临床特征分析
该回顾性研究分析了440例下肢淋巴水肿患者的临床特征,发现慢性静脉功能不全(CVI)是主要病因(41.8%),而非癌症(33.9%)。患者以女性、双侧分布、左腿受累及病态肥胖为特征,25%存在多因素病因,且III期患者蜂窝织炎发生率显著高于II期。
要点
- CVI是下肢淋巴水肿最常见病因(41.8%),超过癌症相关(33.9%)。
- 约25%患者存在多种病因,需全面评估。
- III期淋巴水肿患者软组织感染率约为II期的两倍(61.7% vs 31.8%)。
核心结论
- 在癌症相关物理治疗部门治疗的下肢淋巴水肿患者中,CVI(静脉淋巴水肿)是主要病因,而非癌症。
研究设计与样本
- 为期3年的回顾性分析,纳入440例因下肢淋巴水肿接受淋巴物理治疗的患者,来自大学医学中心癌症相关物理治疗部门。
主要发现
- 下肢淋巴水肿四大病因为CVI(41.8%)、癌症相关(33.9%)、原发性(12.5%)和脂肪水肿继发淋巴水肿(11.8%)。
- 队列以女性为主(71.1%,P < .0001),白人为主(78.9%,P < .0001),双侧分布常见(74.5%,P < .0001),左腿受累多见(双侧69.1%,P < .0001;单侧58.9%,P = .0588)。
- 平均体重和BMI分别为115.8 kg和40.2 kg/m2,且与更高的国际淋巴学会淋巴水肿分期显著相关(III期平均体重和BMI 169.2 kg和57.3 kg/m2 vs II期107.8 kg和37.5 kg/m2,P < .0001)。
- 35.7%的患者发生过一次或多次蜂窝织炎,III期患者软组织感染率约为II期的两倍(61.7% vs 31.8%,P < .001)。
- 多因素淋巴水肿占25%;脂肪水肿继发淋巴水肿(48.1%)或原发性淋巴水肿(45.5%)患者中约半数叠加其他肿胀原因,通常为CVI;全膝关节置换术是非癌症手术导致原有淋巴水肿加重的最常见原因。
临床怎么用
- 临床遇下肢淋巴水肿应优先评估CVI,并注意多病因共存可能。
- 对肥胖患者应关注淋巴水肿分期及蜂窝织炎风险,尤其是III期患者。
局限性
- 回顾性研究,样本来自癌症相关物理治疗部门,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower extremity lymphedema is frequently encountered in the vascular clinic. Established dogma purports that cancer is the most common cause of lower extremity lymphedema in Western countries, whereas chronic venous insufficiency (CVI) is often overlooked as a potential cause. Moreover, lymphedema is typically ascribed to a single cause, yet multiple causes can coexist. METHODS: A 3-year retrospective analysis was conducted of demographic and clinical characteristics of 440 eligible patients with lower extremity lymphedema who presented for lymphatic physiotherapy to a university medical center's cancer-based physical therapy department. RESULTS: The four most common causes of lower extremity lymphedema were CVI (phlebolymphedema; 41.8%), cancer-related lymphedema (33.9%), primary lymphedema (12.5%), and lipedema with secondary lymphedema (11.8%). The collective cohort was more likely to be female (71.1%; P < .0001), to be white (78.9%; P < .0001), to demonstrate bilateral distribution (74.5%; P < .0001), and to have involvement of the left leg (bilateral, 69.1% [P < .0001]; unilateral, 58.9% [P = .0588]). Morbid obesity was pervasive (mean weight and body mass index, 115.8 kg and 40.2 kg/m2, respectively) and significantly correlated with a higher International Society of Lymphology lymphedema stage (stage III mean weight and body mass index, 169.2 kg and 57.3 kg/m2, respectively, vs stage II, 107.8 kg and 37.5 kg/m2, respectively; P < .0001). Approximately one in three (35.7%) of the population sustained one or more episodes of cellulitis, but patients with stage III lymphedema had roughly twice the rate of soft tissue infection as patients with stage II, 61.7% vs 31.8%, respectively (P < .001). Multifactorial lymphedema was present in 25%. Approximately half of the patients with lipedema with secondary lymphedema (48.1%) or primary lymphedema (45.5%) had a superimposed cause of swelling that was usually CVI. Total knee arthroplasty was the most common cause of noncancer surgery-mediated worsening of pre-existing lymphedema. CONCLUSIONS: In a large cohort of patients treated in a cancer-affiliated physical therapy department, CVI (phlebolymphedema), not cancer, was the predominant cause of lower extremity lymphedema. One in four patients had more than one cause of lymphedema. Notable clinical characteristics included a proclivity for female patients, bilateral distribution, left limb, cellulitis, and nearly universal morbid obesity.
引用
- Dean SM, Valenti E, Hock K, et al. The clinical characteristics of lower extremity lymphedema in 440 patients. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 31992537. doi:10.1016/j.jvsv.2019.11.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。